A randomized, controlled, double-blind study of the safety and tolerability of Sandimmun Neoral in stable renal transplant patients. Argentine Multicentre Study Group.
Massari
P U
PU
Hospital Privado de Córdoba-Centro Médico de Córdoba, Argentina.
Grosso
S
S
de Boccardo
G
G
Vásquez
M C
MC
Schiavelli
R O
RO
Sabbatiello
R R
RR
Casadei
D H
DH
Rial
M C
MC
Jost
L J
LJ
Túrin
M D
MD
Agost Carreño C
A
A
Maggiora
E C
EC
Gadea
M M
MM
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D012449:Safety; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine